tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

RLAY Stock Latest News

Relay Therapeutics price target lowered to $19 from $29 at Raymond James
The FlyRelay Therapeutics price target lowered to $19 from $29 at Raymond James
6d ago
RLAY
Relay Therapeutics Reports Q2 2025 Financial Results and Progress
PremiumCompany Announcements
Relay Therapeutics Reports Q2 2025 Financial Results and Progress
7d ago
RLAY
Relay Therapeutics reports Q2 EPS (41c), consensus (47c)
PremiumThe Fly
Relay Therapeutics reports Q2 EPS (41c), consensus (47c)
7d ago
RLAY
Relay Therapeutics’ Phase 3 Study: A New Hope for Advanced Breast Cancer Treatment
PremiumCompany Announcements
Relay Therapeutics’ Phase 3 Study: A New Hope for Advanced Breast Cancer Treatment
13d ago
RLAY
Relay Therapeutics has positive read from Celcuity data, says Barclays
PremiumThe Fly
Relay Therapeutics has positive read from Celcuity data, says Barclays
17d ago
CELC
RLAY
Claire Mazumdar Joins Relay Therapeutics as Director
PremiumCompany AnnouncementsClaire Mazumdar Joins Relay Therapeutics as Director
2M ago
8K
RLAY
Relay Therapeutics Holds 2025 Annual Stockholder Meeting
Premium
Company Announcements
Relay Therapeutics Holds 2025 Annual Stockholder Meeting
2M ago
8K
RLAY
Relay Therapeutics Announces Lease Termination Agreement
Premium
Company Announcements
Relay Therapeutics Announces Lease Termination Agreement
2M ago
8K
RLAY
Relay Therapeutics announces updated data for RLY-2608 with Fulvestrant
PremiumThe Fly
Relay Therapeutics announces updated data for RLY-2608 with Fulvestrant
2M ago
RLAY
Relay Therapeutics price target lowered to $10 from $30 at Guggenheim
PremiumThe Fly
Relay Therapeutics price target lowered to $10 from $30 at Guggenheim
3M ago
RLAY
3 Best Stocks to Buy Now, 5/7/2025, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Now, 5/7/2025, According to Top Analysts
3M ago
ALAB
PRTH
Oncology stocks ‘bearing the brunt’ of Prasad news, says Oppenheimer
PremiumThe Fly
Oncology stocks ‘bearing the brunt’ of Prasad news, says Oppenheimer
3M ago
IDYA
NRIX
Relay Therapeutics: Awaiting Significant Catalysts Amidst Strong Cash Position and Pipeline Potential
PremiumRatingsRelay Therapeutics: Awaiting Significant Catalysts Amidst Strong Cash Position and Pipeline Potential
3M ago
RLAY
Relay Therapeutics Extends Cash Runway and Advances Clinical Trials
Premium
Company Announcements
Relay Therapeutics Extends Cash Runway and Advances Clinical Trials
3M ago
RLAY
Relay Therapeutics reports Q1 EPS (46c), consensus (48c)
Premium
The Fly
Relay Therapeutics reports Q1 EPS (46c), consensus (48c)
3M ago
RLAY
Is RLAY a Buy, Before Earnings?
PremiumPre-Earnings
Is RLAY a Buy, Before Earnings?
3M ago
RLAY
Relay Therapeutics initiated with an Equal Weight at Wells Fargo
PremiumThe Fly
Relay Therapeutics initiated with an Equal Weight at Wells Fargo
4M ago
RLAY
Strategic Operational Changes and Financial Stability Bolster Relay Therapeutics’ Buy Rating
PremiumRatings
Strategic Operational Changes and Financial Stability Bolster Relay Therapeutics’ Buy Rating
4M ago
RLAY
Relay Therapeutics weakness brings buying opportunity, says Barclays
PremiumThe Fly
Relay Therapeutics weakness brings buying opportunity, says Barclays
5M ago
RLAY
Relay Therapeutics weakness brings buying opportunity, says Barclays
PremiumThe FlyRelay Therapeutics weakness brings buying opportunity, says Barclays
5M ago
RLAY
Relay Therapeutics: Promising Clinical Trials and Strategic Positioning Justify Buy Rating
Premium
Ratings
Relay Therapeutics: Promising Clinical Trials and Strategic Positioning Justify Buy Rating
5M ago
RLAY
Buy Rating for Relay Therapeutics Amid Strategic Clinical Progress and Resource Optimization
Premium
Ratings
Buy Rating for Relay Therapeutics Amid Strategic Clinical Progress and Resource Optimization
5M ago
RLAY

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >